Pharmaceuticals and pharmaceutical products in the nature of histone deacetylase (HDAC) inhibitors for the treatment of cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseases; pharmaceuticals and pharmaceutical products for treating cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic infla...

Pharmaceuticals and pharmaceutical products in the nature of histone deacetylase (HDAC) inhibitors for the treatment of cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseases; pharmaceuticals and pharmaceutical products for treating cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic infla...